Can I Get Medical Cannabis on the NHS for Chronic Nausea Outside Chemotherapy?

Medical cannabis has been a hot topic in the UK since its rescheduling in 2018. Yet questions abound about whether patients suffering from chronic nausea unrelated to chemotherapy can access cannabis-based medicines through the NHS. This post unpacks everything you get more info need to know about NHS cannabis eligibility, NHS prescribing guidance on cannabis, the role of specialist-only prescribing, and how the NHS views unlicensed cannabis-based products. Plus, we explain why the law and NHS funding don’t always line up—and where to look for reliable information if you’re ms spasticity thc CBD spray considering this treatment.

The 2018 Rescheduling: What Changed for Medical Cannabis?

Before November 2018, cannabis was a Schedule 1 drug under the Misuse of Drugs Regulations in the UK. This meant medical use was effectively illegal and doctors could not prescribe cannabis-based products. The government’s decision to reclassify cannabis-based products for medicinal use (CBPMs) to Schedule 2 marked a big shift:

Doctors on the Specialist Register could now legally prescribe certain cannabis-based medicines.
This opened the door for research and clinical use within a regulatory framework.
However, restrictions remain tight: only specialist doctors in certain fields can prescribe, and mainly when other treatments have failed.

In simple terms: Since 2018, it’s legal for some specialists to prescribe cannabis medicines—but that doesn’t mean they’ll say yes for just any condition.

Legal Prescribing vs NHS Funding: What’s the Difference?

A key confusion is between what’s legal and what the NHS will actually pay for. Let’s break this down:

Legal Prescribing: Since 2018, specialist doctors can write prescriptions for licensed cannabis-based products in the UK, where clinically appropriate.
NHS Funding: The NHS has stringent rules about what medicines it will routinely fund. So even if a cannabis medicine is legal, it might not be routinely funded (that means you might have to pay privately).

For example, NHS England’s current stance is cautious; it’s mainly funding cannabis-based meds for very specific indications, such as vomiting and nausea caused by chemotherapy. For other uses, including chronic nausea unrelated to chemotherapy, NHS funding is not routinely available.

Translation for patients: “Even if your doctor says you could benefit from medical cannabis, your NHS won’t necessarily pay for it unless you fit very specific rules.”

Specialist-Only Prescribing: The Gatekeeper Role

Another important detail is the requirement that only specialists—not GPs—can prescribe cannabis-based medicines on the NHS. This applies to all CBPMs, including licensed products and some unlicensed ones like nabilone.

Specialists typically work in neurology, pain management, palliative care, or gastroenterology (for nausea issues).
They assess whether standard treatments have been tried and failed before considering cannabis medicines.

For chronic nausea outside of chemotherapy, a specialist such as a gastroenterologist would need to determine if cannabis-based treatment is appropriate. This is no “walk-in” prescription; it’s assessed on a case-by-case basis with detailed clinical rationale required.

About Nabilone and Its NHS Status

Nabilone is a licensed synthetic cannabinoid prescribed for nausea and vomiting but is not a direct cannabis product. It has sometimes been offered as an alternative for nausea, including in cases outside chemotherapy settings.

While nabilone can be prescribed on the NHS, it’s usually only after other antiemetic medicines have been tried.
Availability can vary regionally via local formulary decisions and specialist access policies.
It is sometimes confused with whole-plant cannabis medicines but is a chemically manufactured drug with different regulatory and funding pathways.

Unlicensed Cannabis-Based Medicines and NHS Caution

Many cannabis-based treatments available are unlicensed—meaning they haven’t gone through the full MHRA regulatory approval process for medicines. Examples include some cannabis oils or extracts prescribed off-label.

The NHS is cautious about unlicensed CBPMs because:

Evidence on effectiveness and safety is limited or mixed.
There are concerns about quality, consistency, and dosing.
Funding for unlicensed medicines is even more limited, often requiring individual funding requests.

In practice, this caution greatly restricts routine NHS prescribing of unlicensed cannabis medicines for chronic nausea or other conditions outside well-established indications.

Where Can Patients Go for More Information and Support?

If you’re considering medical cannabis for chronic nausea not related to chemotherapy, here are some useful resources:

medicalcannabis.co.uk – a directory and comparison site listing UK clinics offering cannabis-based medicine consultations (mostly private); useful for understanding costs and treatment options.
releaf.co.uk – provides clear explainer articles on medical cannabis laws, eligibility, and NHS policy.

Note that as of now, prices for cannabis-based medicines on the NHS are not routinely published and can vary widely for private prescriptions. No specific prices were stated in available public NHS information. If price details emerge from reliable sources, these should be quoted exactly and properly attributed.

Summary: Can You Get NHS Medical Cannabis for Chronic Nausea Outside Chemotherapy?

Condition Legal Prescribing NHS Funding Typical Prescriber Notes Nausea related to chemotherapy Yes, by specialists Usually funded, with NHS England approval Oncology specialists Most established indication for NHS cannabis Chronic nausea unrelated to chemotherapy In theory, possible by specialists Not routinely funded; requires case-by-case approval Gastroenterologists or other specialists NHS is cautious; evidence limited Use of nabilone for nausea Yes Variable depending on region and indication Specialists Licensed synthetic cannabinoid, sometimes used when other drugs fail

Key Takeaways

Medical cannabis prescribing on the NHS is legal but tightly controlled.
Only specialists can prescribe, with strict criteria and usually after other treatments have failed.
NHS funding covers mainly chemotherapy-related nausea; other uses are rarely funded and require individual evaluation.
Unlicensed cannabis products face additional hurdles and NHS caution due to limited evidence.
If interested in private routes, consult resources like medicalcannabis.co.uk for clinics and releaf.co.uk for guidance.

If you’re a patient hoping for NHS cannabis treatment for chronic nausea outside chemotherapy, the honest answer is that it’s unlikely to be routinely funded—but a specialist might consider it on an individual basis. Always discuss thoroughly with your healthcare team and check reliable resources before making decisions.